COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem

References

• Ebina S, Seki M, Karaushi H, Shimizu A, Mitsutake K. Antibiotic prescriptions for COVID 19 patients increased during the BA.5 period. World J Med Microbiol. 2023;2(2):11–13.
   Google Scholar
• Bahceci I, Yildiz IE, Duran OF, et al. Secondary bacterial infection rates among patients with COVID-19. Cureus. 2022;14(2):e22363. doi:10.7759/cureus.22363
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary bacterial infections in patients with viral pneumonia. Front Med. 2020;5:420.
   Google Scholar
• Manohar P, Loh B, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary bacterial infections in patients with viral pneumonia. Front Med. 2020;7:420. doi:10.3389/fmed.2020.00420
   PubMed Web of Science ®Google Scholar
• Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1):72–79. doi:10.1164/rccm.200909-1420OC
   PubMed Web of Science ®Google Scholar
• Franch-Llasat D, Bellaubí-Pallarés N, Pérez-Moreno MO, Chamarro-Martí E, García-Rodríguez E, Roche-Campo F. Pneumococcal meningitis secondary to otitis media in two patients with COVID-19 omicron variant. Int J Emerg Med. 2022;15(1):50. doi:10.1186/s12245-022-00448-y
   PubMed Web of Science ®Google Scholar
• Brueggemann AB, Jansen van Rensburg M, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360–e70. doi:10.1016/S2589-7500(21)00077-7
   PubMedGoogle Scholar
• Pagliano P, Ascione T, Boccia G, De Caro F, Esposito S. Listeria monocytogenes meningitis in the elderly: epidemiological, clinical and therapeutic findings. Infez Med. 2016;24(2):105–111.
   PubMedGoogle Scholar
• Tateda K, Ishii Y, Matsumoto T, Yamaguchi K. Break-point checkerboard plate’ for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scand J Infect Dis. 2006;38(4):268–272. doi:10.1080/00365540500440353
   PubMed Web of Science ®Google Scholar
• Kataoka H, Ida T, Ishii Y, et al. Analysis of the influence of drug resistance factors on the efficacy of combinations of antibiotics for multidrug-resistant Pseudomonas aeruginosa isolated from hospitals located in the suburbs of Kanto area, Japan. J Glob Antimicrob Resist. 2013;1(2):91–96. doi:10.1016/j.jgar.2013.03.005
   PubMed Web of Science ®Google Scholar
• de Noordhout CM, Devleesschauwer B, Angulo FJ, et al. The global burden of listeriosis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(11):1073–1082. doi:10.1016/S1473-3099(14)70870-9
   PubMed Web of Science ®Google Scholar
• Jackson K, Gould L, Hunter JC, Kucerova Z, Jackson B. Listeriosis outbreaks associated with soft cheeses, United States, 1998–2014. Emerg Infect Dis. 2018;24(6):1116–1118. doi:10.3201/eid2406.171051
   PubMed Web of Science ®Google Scholar
• McCollum JT, Cronquist AB, Silk BJ, et al. Multistate outbreak of listeriosis associated with cantaloupe. N Engl J Med. 2013;369(10):944–953. doi:10.1056/NEJMoa1215837
   PubMed Web of Science ®Google Scholar
• Marcus R, Hurd S, Mank L, et al. Chicken salad as the source of a case of Listeria monocytogenes infection in Connecticut. J Food Prot. 2009;72(12):2602–2606. doi:10.4315/0362-028X-72.12.2602
   PubMed Web of Science ®Google Scholar
• Swaminathan B, Gerner-Smidt P. The epidemiology of human listeriosis. Microbes Infect. 2007;9(10):1236–1243. doi:10.1016/j.micinf.2007.05.011
   PubMed Web of Science ®Google Scholar
• Veras FP, Pontelli MC, Silva CM, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129. doi:10.1084/jem.20201129
   PubMed Web of Science ®Google Scholar
• Krasemann S, Haferkamp U, Pfefferle S, et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17(2):307–320. doi:10.1016/j.stemcr.2021.12.011
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5
   PubMed Web of Science ®Google Scholar
• Temple ME, Nahata MC. Treatment of listeriosis. Ann Pharmacother. 2000;34(5):656–661. doi:10.1345/aph.19315
   PubMed Web of Science ®Google Scholar
• Mitjà O, Pigrau C, Ruiz I, et al. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother. 2009;64(2):416–423. doi:10.1093/jac/dkp180
   PubMed Web of Science ®Google Scholar
• Amaya-Villar R, García-Cabrera E, Sulleiro-Igual E, et al. Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults. BMC Infect Dis. 2010;11(10):324. doi:10.1186/1471-2334-10-324
   Google Scholar
• Cunha CB, Cunha BA. Antibiotic Essentials. 17th ed. London, UK: Jaypee Brothers Medical Publishers Pvt Ltd; 2020.
   Google Scholar
• Winslow D, Pankey GA. In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes. Antimicrob Agents Chemother. 1982;22(1):1116–1118. doi:10.1128/AAC.22.1.51
   Web of Science ®Google Scholar
• Polat M, Kara SS, Tapısız A, Derinöz O, Çağlar K, Tezer H. Successful treatment of refractory listeria meningitis and bacteremia with trimethoprim-sulfamethoxazole in an immunocompetent child. Turk J Pediatr. 2016;58(2):220–222. doi:10.24953/turkjped.2016.02.017
   PubMed Web of Science ®Google Scholar